GlassScriptPhysician profile
Taki Galanis
NPI 1013112051
$13,347.91
in general payments reported to CMS, 2019-2025
14 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,283 · 2020: $3,455 · 2021: $1,029 · 2022: $4,061 · 2023: $934 · 2024: $398 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12,222.58 | 2019-2023 | Xarelto |
| Inari Medical, INC. | $358.97 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $175.56 | 2019-2024 | Collagenase Santyl, Regranex |
| Novartis Pharmaceuticals Corporation | $148.73 | 2023-2025 | |
| Penumbra, INC. | $144.38 | 2024 | Ruby Coil |
| Amgen INC. | $95.07 | 2022-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $75.00 | 2023-2025 | Eliquis, Camzyos |
| Daiichi Sankyo INC. | $28.39 | 2022 | |
| Kerecis Limited | $24.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Heartflow, INC. | $23.40 | 2025 | |
| Argon Medical Devices, INC. | $19.41 | 2025 | Clot Management |
| Stryker Corporation | $17.39 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $14.26 | 2024 | Eluvia |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taki Galanis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.